Table 3.
Evaluation of therapeutic efficacy after treatment in both groups
| Tumor response | Control group (n = 71) | Research group (n = 66) | t/χ2 | P |
|---|---|---|---|---|
| CR | 5 (7.04) | 9 (13.64) | 4.955 | 0.175 |
| PR | 18 (25.35) | 23 (34.85) | ||
| PD | 28 (39.44) | 15 (22.73) | ||
| SD | 20 (28.17) | 19 (28.79) | ||
| ORR | 32.39% | 48.49% | 3.685 | 0.055 |
| DCR | 60.56% | 77.27% | 4.435 | 0.035 |
Note: CR, Complete Response; PR, Partial Response; PD, Progressive Disease; SD, Stable Disease; ORR, Overall Response Rate; DCR, Disease Control Rate.